Back to search results

Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Avian Influenza A Virus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Centro de Terapias Avançadas E Inovadoras - Ct Terapias/Ufmg, Belo Horizonte, Minas Gerais, Brazil

    Contact: Study coordinator (Mauro MD Teixeira, PhD) · mmtex.ufmg@gmail.com · (31)2520-4008

  • Plátano Centro de Pesquisa Clínica LTDA, Recife, Pernambuco, Brazil

    Contact: Study coordinator (Carlos MD Brito, PhD) · cbritoc@gmail.com · (81)99127-7732

  • Fundação Faculdade Regional de Medicina de São Jose do Rio Preto - (Centro integrado de Pesquisa CIP), São José do Rio Preto, São Paulo, Brazil

    Contact: Study coordinator (Mauricio MD Nogueira, PhD) · mauricio.nogueira@edu.famerp.br · (17)98811-0550

  • Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preta da Universidade de São Paulo - (Centro de Pesquisa Clínica - S), Serrana, São Paulo, Brazil

    Contact: Study coordinator (Marcos MD Borges, PhD) · marcosborges@fmrp.usp.br · (16)98116-5608

  • Centro de Pesquisas Clínicas do Hospital das Clínicas da FMUSP, São Paulo, Brazil

    Contact: Study coordinator (Ferdinando MD Menezes, PhD) · f.menezes@hc.fm.usp.br · (11)98373-2290
View source on ClinicalTrials.gov(opens in a new tab)